PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Symptom | |pulmonary hypertension |
| Sentences | 109 |
| PubMedID- 20459681 | 3 years old female patient, known case of congenital heart disease with pulmonary hypertension and cerebral palsy was admitted to the hospital on 7th october 2009 with high grade of fever, cough, sore throat, difficulty in breathing and body aches. |
| PubMedID- 26504732 | The treatment of choice for pulmonary hypertension due to left heart disease (group 2), due to lung disease (group 3) or due to unclear multifactorial mechanisms (group 5) is the state-of-the-art therapy of the underlying disease. |
| PubMedID- 25011987 | Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. |
| PubMedID- 23559349 | There has been no established medical therapy to ameliorate pulmonary hypertension (ph) owing to left heart disease (lhd-ph). |
| PubMedID- 23906950 | Group 2 comprises pulmonary hypertension owing to left heart disease; group 3, pulmonary hypertension owing to lung diseases and/or hypoxia; group 4, chronic thromboembolic pulmonary hypertension; and group 5, pulmonary hypertension of unknown cause. |
| PubMedID- 26471823 | There are several mechanisms of pulmonary hypertension in patients with adult congenital heart disease, and understanding them requires a systematic approach to define the patient's hemodynamics and physiology. |
| PubMedID- 22169723 | Objective: to explore the effect of unidirectional valved patch (uvp) for congenital heart disease (chd) with severe pulmonary hypertension (ph). |
| PubMedID- 20814475 | The introduction of inhaled nitric oxide (ino) has added a new dimension to the treatment of pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 23890862 | Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 24267298 | It is uncertain whether therapies for pulmonary arterial hypertension have any role in treating pulmonary hypertension owing to left heart disease, and there are safety concerns with these agents in this population. |
| PubMedID- 20924360 | pulmonary hypertension (ph) with left-sided heart disease is defined, according to the latest venice classification, as a group 2 ph, which includes left-sided ventricular or atrial disease, and left-sided valvular diseases. |
| PubMedID- 23130100 | this regression is not observed in patients with congenital heart disease associated with pulmonary hypertension, which may contribute to their relatively good outcome compared to patients with pah. |
| PubMedID- 25981561 | Plasma levels of acylated ghrelin in children with pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 25701970 | Conclusion: the results of this pilot study suggest that endothelin receptor antagonism improves the functional status of patients with tte evidence of pulmonary hypertension due to valvular heart disease. |
| PubMedID- 22068738 | pulmonary hypertension due to left heart disease (systolic or diastolic dysfunction, valvular disease)3. pulmonary hypertension due to lung diseases and/or hypoxia (such as chronic obstructive pulmonary disease, interstitial lung diseases, and others)4. chronic thrombo-embolic pulmonary hypertension5. |
| PubMedID- 26440237 | Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children. |
| PubMedID- 24829371 | pulmonary hypertension in adults with congenital heart disease and eisenmenger syndrome: current advanced management strategies. |
| PubMedID- 24358351 | pulmonary hypertension due to left heart disease (group ii) and associated with chronic lung disease (group iii) are the most commonly observed ph groups in the population . |
| PubMedID- 20494465 | Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 23015200 | No medical treatment has been established to ameliorate pulmonary hypertension (ph) due to left heart disease. |
| PubMedID- 24999252 | Background: pulmonary hypertension (ph) associated with left heart disease (world health organization who group ii) has previously been linked with significant morbidity and mortality. |
| PubMedID- 22313804 | Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. |
| PubMedID- 20862619 | pulmonary hypertension due to left heart disease: recommendations of the cologne consensus conference 2010. |
| PubMedID- 23213519 | pulmonary hypertension due to left heart disease (clinical group 2) is defined as postcapillary (pulmonary capillary wedge pressure ≥ 15 mmhg) while precapillary (pulmonary capillary wedge pressure ≤ 15 mmhg) pulmonary hypertension presents in other groups. |
| PubMedID- 25705390 | Controversies in pulmonary hypertension due to left heart disease. |
| PubMedID- 22837863 | Indeed, in murine models of pulmonary hypertension associated with left heart disease and in monocrotaline-induced rodent pulmonary hypertension, treatment with a mast cell stabilizer or use of mast cell deficient rats attenuated vascular remodeling. |
| PubMedID- 22720870 | +: p < 0.05 in comparison to group 3, pulmonary hypertension owing to left heart disease (ph-lhd). |
| PubMedID- 22015568 | This classification is characterized by division into five groups: pulmonary arterial hypertension (pah); pulmonary hypertension due to left heart disease; pulmonary hypertension due to lung disease and/or hypoxia; chronic thromboembolic pulmonary hypertension; and pulmonary hypertension with unclear and/or multifactorial mechanisms. |
| PubMedID- 26339897 | In ssc, because of the great variability in clinical manifestation, it is possible to identify pulmonary hypertension due to left heart disease, ph due to respiratory disease or pulmonary arterial hypertension. |
| PubMedID- 22748905 | pulmonary hypertension associated with left-sided heart disease. |
| PubMedID- 24361805 | Background: pulmonary hypertension due to left heart disease is very common. |
| PubMedID- 22526220 | Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 25610841 | Patients with symptoms and signs of heart failure with pcwps of 13–15 mmhg and elevated pulmonary artery pressures may pose a diagnostic challenge as they do not fulfill the esc definition of pulmonary hypertension due to left heart disease where a cut-off value of 15 mmhg to differentiate between pre- and post-capillary pulmonary hypertension was used . |
| PubMedID- 20144487 | Minimum-intensity projection of multidetector-row computed tomography for assessment of pulmonary hypertension in children with congenital heart disease. |
| PubMedID- 23351920 | Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease. |
| PubMedID- 26291842 | Palliative senning in the treatment of congenital heart disease with severe pulmonary hypertension. |
| PubMedID- 24739042 | The current classification is based on the who-conference in nice (2013)1 and separates the term pulmonary arterial hypertension (pah) from pulmonary hypertension (ph) due to left heart disease, pulmonary disease, chronic thromboembolic pulmonary hypertension (cteph) and ph of miscellaneous etiologies. |
| PubMedID- 24561861 | Patients with pulmonary hypertension associated with congenital heart disease survive longer with preserved right ventricular (rv) function compared with those with primary pulmonary hypertension. |
| PubMedID- 26261613 | Objective: to investigate the relationship between p-selectin gene polymorphism and congenital heart disease (chd) with pulmonary hypertension (pah). |
| PubMedID- 23158820 | Conclusion: there was the expression of urotensin ii protein and mrna in the lung of pulmonary hypertension patients with congenital heart disease, and these expression may involve the formation of pulmonary hypertension of congenital heart disease. |
| PubMedID- 23932041 | Objectives: the two hemodynamic profiles in left heart disease (lhd) with pulmonary hypertension (ph), passive ph with increased pulmonary venous pressure and reactive ph with increased pulmonary vascular resistance (pvr > 3 wood units, wu), are difficult to distinguish non-invasively. |
| PubMedID- 25737007 | Asymmetric dimethyl-l-arginine is a biomarker for disease stage and follow-up of pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 24826287 | Heart transplantation in a 14-year-old boy in the presence of severe out-of-proportion pulmonary hypertension due to restrictive left heart disease: a case report. |
| PubMedID- 21712881 | pulmonary hypertension, with congenital heart disease, is seen in large systemic-to-pulmonary communications, such as ventricular septal defect (vsd) and patent ductus arteriosus. |
| PubMedID- 26046840 | Methods: in a prospective cohort of patients with right heart catheterization, we identified 73 adult patients who had pulmonary hypertension due to left heart disease (ph-lhd) associated with hfpef (left ventricular ejection fraction >/=50% by echocardiography); hemodynamically defined as a mean pulmonary artery pressure >/=25 mm hg and pulmonary artery wedge pressure >15 mm hg. |
| PubMedID- 23789186 | This article gives an overview of the importance and pathophysiology of pulmonary hypertension associated with left heart disease, and discusses the challenges associated with its diagnosis and treatment. |
| PubMedID- 21069290 | Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. |
| PubMedID- 20646560 | The actuarial survival analysis to the surgical and non-surgical therapy regime for congenital heart disease with severe pulmonary hypertension. |
| PubMedID- 24771555 | The majority had idiopathic pulmonary arterial hypertension (n=30); the remaining patients had pulmonary hypertension associated with repaired congenital heart disease (n=17) or lung disease (n=3). |
| PubMedID- 26203294 | Chronic left heart diseases with secondary pulmonary hypertension (group 2 of pulmonary hypertension classification10). |